• Biography

    Jeffrey Wolfson, head of the Patent Prosecution Practice Group, helps clients from Fortune 500 enterprises to start-ups manage their intellectual property and related legal risk, both in obtaining and managing portfolios of U.S. and foreign patent and other IP rights, including patent prosecution and IP-related commercial agreements, and in counseling clients regarding their key product and service launches and related design-around opportunities. Jeff has assisted clients across various industries on technologies such as generic pharmaceuticals, drug delivery devices and materials, petroleum automation technology, behavioral and predictive communication routing and analytics, automotive polymers, food products and processing, leisure and sporting goods, and more.

    With more than 22 years of experience advising clients on a wide range of patent and other intellectual property issues, Jeff has in-depth experience representing clients outside the courtroom to minimize the risk of IP litigation, and to tip the strategic strengths when it cannot be avoided. By obtaining patents while considering the latest Federal Circuit and Supreme Court decisions; negotiating and drafting licenses, distribution and other agreements while considering critical client business goals; and counseling clients on critical IP issues when developing new products and services, Jeff acts as a trusted business advisor to his clients as they face competitive headwinds.

    Jeff, a registered patent lawyer with a chemical engineering education, provides representation at the USPTO; has obtained numerous U.S. and foreign patents; prepared hundreds of invalidity, non-infringement, patentability, freedom-to-operate, and other product clearance opinions; and has conducted numerous IP diligence evaluations in connection with mergers, acquisitions, and secured financial transactions. Jeff is frequently asked to speak to IP organizations and trade associations on a variety of topics, including IP issues in Mergers and Acquisitions, patent prosecution and the effects of the America Invents Act, inter partes review proceedings, and the U.S. Biosimilars regulatory framework.

    Clients and colleagues have generously rewarded Jeff with accolades including being recognized in Washington, D.C. Super Lawyers, Thomson Reuters, for intellectual property, 2013-2017 and awarding him an AV Peer Review Rated Preeminent by Martindale-Hubbell Law Directory. Jeff was also honored in Intellectual Asset magazine's Patent 1000: The World's Leading Patent Practitioners, Globe White Page Ltd, most recently in 2017 for patent prosecution and IP transactions. In his limited spare time, Jeff volunteers regularly for Brown University alumni interviewing, has served as a college class officer for the last 10 years, and enjoys spending time with his family—even including the two teenagers.

  • Education and Clerkships

    • J.D. , George Washington University Law School , 1995 , with honors; Executive Managing Editor, The G.W. Journal of Int'l Law & Economics (now Geo. Wash. Int'l Law Review); Publication Staff, AIPLA Quarterly Journal
    • Sc.B. , Chemical Engineering , Brown University , 1992
  • Admissions

    • Maryland , 1995
    • District of Columbia , 1996
    • U.S. Patent and Trademark Office
  • Court Admissions

    • U.S. Court of Appeals for the Federal Circuit
    • Court of Appeals of Maryland
    • U.S. District Court for the District of Maryland
    • District of Columbia Court of Appeals
    • U.S. District Court for the District of Columbia